Voyageur Proceeds To Progress It’s One of a kind Comprehensive Integration System For The Radiology Drug Industry
Voyageur Pharmaceuticals Ltd (TSX:VM TSXV)
CALGARY, ALBERTA, CANADA, November 8, 2021 /EINPresswire.com/ — Voyageur Prescribed drugs Ltd. (TSX.V:VM) (United states:VYYRF) (the “Firm” or “Voyageur”) is pleased to announce the signing of a non-binding Memorandum of Comprehending (“MOU”) with Summit Nanotech Corporation (“SNT”). The MOU proposes an arrangement among Voyageur and SNT to develop a additional sustainable course of action for the production of iodine professional medical solutions, that are used as distinction agents. The course of action will be designed by leveraging SNT’s award profitable lithium extraction technology.
There have been no important improvements in processing technology in more than 20 many years in the compounding of iodine professional medical items. SNT’s innovative nanomaterials have the prospective to lessen creation costs and improve generation performance, although also producing a reduced environmental footprint. By collaborating with SNT and working a “green” pharmaceutical producing course of action, Voyageur will lead to a reduction in throughout the world carbon emissions and be certain that their extended-phrase plans align with the United Nations Agenda 2030 Sustainable Growth Strategy.
Brent Willis, CEO of Voyageur states, “By signing up for with SNT, we are fortifying our idea of entirely integrating our functions from earth to bottle. Production contrast brokers that we manage at prices that are decreased than individuals of other iodine producers, will help Voyageur to acquire a competitive edge in the market and help to reduce health care costs throughout the world.”
Amanda Hall, CEO of Summit Nanotech states, “Voyageur’s holistic tactic of mineral extraction from underground brines for iodine, using sustainable procedures, aligns with Summit’s present asset improvement system. By generating new nanomaterials to isolate iodine in tandem with lithium, we are chopping emissions, lessening squander and further more contributing to the round overall economy.”
About Summit Nanotech Company

SNT is a Calgary based corporation that leverages modern advancements in nanotechnology to generate and put into practice options for industrial purposes. By combining their nanotechnology expertise, expertise in biology, chemistry, chemical engineering and mechanical engineering, SNT’s team is in a position to carry a prosperity of benefit to the iodine distinction agent job. Nanotechnology is not a unique technological know-how, it is an revolutionary, if not revolutionary comprehension of how products are created. The capacity to synthesize and manipulate materials at the molecular amount is now doable due to breakthroughs in nanotechnology investigation.

At our core, we are a humancentric company, using ground breaking, resourceful persons. We crack boundaries and observe via with jobs that will alter the industrial landscape. Started by geoscientists with considerable resource growth experience, we feel nanotechnology can be leveraged to provide globe class methods to industrial issues. Why not join our fast-increasing client foundation? Get in contact currently to study much more. https://www.summitnanotech.ca/
About Voyageur

Voyageur is a Canadian public business stated on the TSXV underneath the trading symbol VM. Voyageur is focused on the development of barite and iodine Active Pharmaceutical Substances (“API”) and significant-effectiveness expense-effective imaging distinction agents for the healthcare radiology marketplace. Voyageur’s target is to at first generate favourable cash stream from functions working with third bash GMP pharmaceutical companies in Canada and internationally. Eventually, Voyageur has ideas to establish all the necessary infrastructure to grow to be 100% self-adequate with all production. Voyageur owns a 100% fascination in a few barium sulfate (barite) jobs together with the Frances Creek house, appropriate in grade for the pharmaceutical barite market, with interests in a high-grade iodine, lithium & bromine brine project located in Utah, United states.
Voyageur is shifting forward with its organization prepare of getting to be the only fully integrated organization in the radiology healthcare area, by controlling all principal input expenditures below the motto of: “From the Earth to the Bottle”.
For More Media Information and facts or to established up an interview, be sure to contact:
Brent Willis

President & CEO

E [email protected]
Ron Appreciate

CFO

T 403.818.6086

E [email protected]
Ahead Searching Information and facts

This information release might comprise specific ahead-looking facts and statements, together with without having limitation, statements pertaining to “entering into a definitive agreement with SNT, the usefulness of SNT’s technological innovation to decrease production expenses and maximize production efficiency whilst building a reduce environmental footprint, the growth of a a lot more sustainable method for the generation of iodine medical items and statements relating to the Company’s prolonged time period programs, together with with regard to starting to be 100% self-sufficient with all manufacturing. All statements included herein, other than statements of historical simple fact, are forward-searching data and this kind of details consists of various pitfalls and uncertainties. There can be no assurance that this kind of info will verify to be exact, and genuine results and long term events could differ materially from all those predicted in such info. A description of assumptions used to develop these ahead-looking information and a description of risk variables that might trigger precise effects to differ materially from ahead-on the lookout information can be uncovered in the Company’s disclosure files on the SEDAR web page at www.sedar.com. Voyageur does not undertake to update any ahead-on the lookout information and facts except in accordance with applicable securities regulations.
Reader Advisory

Neither the TSXV nor its Regulation Providers Company (as that expression is described in the guidelines of the TSXV) accepts responsibility for the adequacy or precision of this information launch.
Brent Willis
Voyageur Prescribed drugs Ltd
+ +1 4039235944
email us in this article
